If Trust in Pharma Is Low, Why Are DTC Marketers Still Pouring Money into TV? –

[ad_1] If pharma has a trust problem with patients, then continuing to over-index on DTC TV advertising is fighting with one hand tied behind its back. TV is a safe harbor. It’s predictable. But it’s not designed to address the issues that cause patient skepticism. In the meantime, the patient health seeker online seeks better, more detailed information and…

Read More

What Happens If Pharma Leaves TV? –

[ad_1] We’ve seen them a thousand times: the sun-drenched fields, the happy couples holding hands, and the narrator rattling off a list of scary side effects at lightning speed. TV commercials for prescription drugs are a vast, multi-billion-dollar industry that feels uniquely American. In fact, the U.S. and New Zealand are the only two countries…

Read More

A Case Study in Missing the Mark –

[ad_1] I recently caught a TV spot for Rezdiffra, a treatment for fatty liver disease, and it perfectly encapsulates what’s fundamentally broken about direct-to-consumer (DTC) pharma advertising today. Here’s the problem: The ad jumps straight to branded messaging without any patient education or disease awareness building. No context. No foundation. Just a drug name and…

Read More